Stay updated on Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T02:25:49.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page displays the completed NCT02684253 clinical trial record, including its eligibility criteria, treatment arms, outcome measures, results, publication, and study documents.
    Difference
    53%
    Check dated 2026-11-11T01:35:55.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error rather than the study details.
    Difference
    0.2%
    Check dated 2026-11-03T23:48:21.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    An NIH-wide notice about changing terminology was added above the error page, and the site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:50:43.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:14:35.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the full study record, indicating that access to the page is blocked and no study details are displayed.
    Difference
    19%
    Check dated 2026-09-22T23:53:56.000Z thumbnail image

Stay in the know with updates to Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.